Darvon® and Darvocet® Removed from Market
Xanodyne Pharmaceuticals, Inc., the maker of the painkiller drugs Darvon® and Darvocet®, has withdrawn these medications from the U.S. market at the request of the FDA.
Why are Darvon and Darvocet considered dangerous?
Darvon and Darvocet contain a chemical known as propoxyphene, which is an opioid used to treat mild to moderate pain. It was first approved by the FDA in 1957 and is sold by prescription under various names alone (e.g., Darvon), or in combination with acetaminophen (e.g., Darvocet). Propoxyphene, however, has been linked to serious heart problems.
What is being done to protect consumers?
The FDA has requested that every drug company remove all products containing propoxyphene from the market. According to the FDA, clinical data suggested the drugs put patients at an increased risk for serious or potentially life-threatening heart rhythm abnormalities.
As a result of this data, along with other information, the FDA found that the risks posed by propoxyphene outweighed its pain management benefits.
What symptoms are associated with Darvon or Darvocet use?
The adverse symptoms of Darvon or Darvocet use include:
- heart failure
- heart attack
- sudden cardiac death
We Want to Help
Our law firm is reviewing cases for which objective diagnostic test reports and records are available to document a patient was taking the drug at the time of suffering heart failure, heart attack, or sudden cardiac death. We are also reviewing cases in which individuals suffered hip fracture while taking Darvon, Darvocet, or a propoxyphene-containing drug.
If you or a loved one have suffered serious side effects, or your loved one has died from the use a dangerous drug, you may be able to file a dangerous drug claim. Contact the Law Offices of Michael A. DeMayo, L.L.P. ® to schedule your free initial consultation.
Darvocet and Darvon are registered trademarks of Xanodyne Pharmaceuticals, Inc., and are only used here to identify the products in question. This law firm is not associated with, sponsored by, or affiliated with the Food and Drug Administration or Xanodyne Pharmaceuticals, Inc.